Sort
64,565 grants matching “drug discovery”
Alzheimer's Disease Genetics Consortium
$3,793,371Gerard David Schellenberg · University Of Pennsylvania · U01 · FY2009 · AG
Translating SHIP1 genetics to generate a novel Alzheimer's pharmacologic agent
$3,791,020Steven Estus · University Of Kentucky · RF1 · FY2018 · AG
Pathway discovery, validation and compound identification for Alzheimer's disease
$3,789,650Philip L De Jager · Broad Institute, Inc. · U01 · FY2016 · AG
New Mexico Molecular Libraries Screening Center(RMI)
$3,789,015Larry A. Sklar · University Of New Mexico · U54 · FY2007 · MH
CANCER CENTER SUPPORT
$3,788,640University Of Pittsburgh At Pittsburgh · P30 · FY2000 · CA
Buffalo Clinical and Translational Research Center
$3,786,579Timothy F Murphy · State University Of New York At Buffalo · UL1 · FY2018 · TR
Novel Anticonvulsant and Neuroprotective Therapies for TETS and OP Intoxication
$3,781,279Pamela J Lein · University Of California At Davis · U54 · FY2019 · NS
Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS II)
$3,779,978Oluwaseun Johnson-Akeju · Massachusetts General Hospital · R01 · FY2025 · AG
Whole genome profiling to detect schizophrenia methylation markers
$3,779,294Edwin Van Den Oord · Virginia Commonwealth University · RC2 · FY2009 · MH
Core B: Genomics and Immune Monitoring Shared Resource Core
$3,779,178Elaine R Mardis · Research Inst Nationwide Children'S Hosp · U54 · FY2019 · CA
Novel Anticonvulsant and Neuroprotective Therapies for TETS and OP Intoxication
$3,778,502Pamela J Lein · University Of California At Davis · U54 · FY2020 · NS
Bioanalysis, Drug Metabolism and New Drug Discovery
$3,768,411Josephine Earley · National Institute On Aging · ZIA · FY2021 · AG
Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks
$3,767,729Paul M Thompson · University Of Southern California · U01 · FY2020 · AG
Drug Repurposing Screening for Rare and Neglected Diseases
$3,765,980Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH
$3,764,013Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2010 · RR
Utah Trial Innovation Center
$3,762,097Jonathan Michael Dean · University Of Utah · U24 · FY2020 · TR
In vivo virology core
$3,760,731Adolfo Garcia-Sastre · University Of California, San Francisco · U19 · FY2022 · AI
UAB Research Center of Excellence in Arsenicals
$3,760,317Mohammad Athar · University Of Alabama At Birmingham · U54 · FY2022 · ES
UAB Research Center of Excellence in Arsenicals
$3,760,306Mohammad Athar · University Of Alabama At Birmingham · U54 · FY2021 · ES
UAB Research Center of Excellence in Arsenicals
$3,760,191Mohammad Athar · University Of Alabama At Birmingham · U54 · FY2019 · ES
UAB Research Center of Excellence in Arsenicals
$3,760,067Mohammad Athar · University Of Alabama At Birmingham · U54 · FY2020 · ES
Topographic, cell type and molecular pathway characterization ofAlzheimer's disease using single cell transcriptomics and epigenomics
$3,757,393Ed Lein · Allen Institute · U19 · FY2020 · AG
Novel Anticonvulsant and Neuroprotective Therapies for TETS and OP Intoxication
$3,757,156Pamela J Lein · University Of California At Davis · U54 · FY2017 · NS
DCTD Human Toxicology and Pharmacology
$3,755,545David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA
Genetic epidemiology of complex diseases
$3,747,395Charles Rotimi · National Human Genome Research Institute · ZIA · FY2022 · HG